A 58-year-old man with a 10-year history of type 2 diabetes and hypertension presents with stable angina. His LDL cholesterol is 145 mg/dL despite lifestyle modifications. Coronary angiography reveals 60% stenosis in the left anterior descending artery. Which drug is the first-line agent to reduce his cardiovascular risk and slow atherosclerotic progression?

Explanation

## Rationale for Statin as First-Line Therapy **Key Point:** Statins are the gold-standard first-line agents for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD). They reduce LDL cholesterol by 30–55% and lower cardiovascular events by ~30% independent of baseline LDL. ### Mechanism of Action Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. This leads to: 1. Decreased hepatic cholesterol production 2. Upregulation of LDL receptors 3. Enhanced clearance of LDL from circulation 4. Pleiotropic anti-inflammatory and plaque-stabilizing effects ### Evidence Base **High-Yield:** Major trials (4S, WOSCOPS, CARE, LIPID, HPS, ASCOT-LLA) demonstrate that statins reduce: - Myocardial infarction incidence - Stroke risk - Cardiovascular mortality - All-cause mortality (in secondary prevention) ### Comparison with Other Lipid-Lowering Agents | Agent | Role | When Used | |-------|------|----------| | **Statin** | First-line; reduces LDL 30–55% | All patients with ASCVD or high risk | | **Ezetimibe** | Adjunctive; reduces LDL 15–20% | Added if statin monotherapy insufficient | | **Bempedoic acid** | Uricosuric; reduces LDL 15–20% | Statin-intolerant patients (newer agent) | | **PCSK9 inhibitor** | Potent; reduces LDL 50–70% | Statin-intolerant or very high-risk patients | **Clinical Pearl:** In this patient with diabetes, hypertension, and angiographic CAD (secondary prevention), high-intensity statin therapy (e.g., atorvastatin 40–80 mg daily) is guideline-mandated. The LDL goal is typically <70 mg/dL or even <55 mg/dL in very high-risk patients. **Mnemonic:** **STATIN** = **S**tatin **T**herapy **A**ddresses **T**hree **I**ssues **N**ow (LDL reduction, plaque stabilization, inflammation suppression). ## Why This Patient Needs a Statin - Established CAD (60% LAD stenosis) = secondary prevention - Diabetes + hypertension = high-risk phenotype - LDL 145 mg/dL = above goal - No contraindication mentioned (normal liver/muscle function assumed)